What is Exome Boosting?
Since 2023, 3billion has continuously improved its exome panel to identify hard-to-detect variants—such as mitochondrial heteroplasmy, deep intronic mutations, and noncoding gene variants.
These updates have already led to diagnoses in 160 previously unsolved cases,
with 78% diagnosed through mitochondrial genome coverage alone.
🧬 What’s new in 3B-EXOME V2:
-
Mitochondrial genome coverage increased from 200x → 2000x
-
Noncoding genes like RNU4-2 and CHASERR now included
-
Full intron & CNV coverage of 25 genes linked to available therapies
📘Download the Exome Boosting brochure
Get the data, performance insights, and real-world results.
Fill out the form below to receive your copy via email.